347 related articles for article (PubMed ID: 16163622)
1. Reactive Epstein-Barr virus-related polyclonal lymphoproliferative disorder in a patient with AIDS.
Martin SI; Zukerberg L; Robbins GK
Clin Infect Dis; 2005 Oct; 41(8):e76-9. PubMed ID: 16163622
[TBL] [Abstract][Full Text] [Related]
2. Monitoring of Epstein-Barr virus load after hematopoietic stem cell transplantation for early intervention in post-transplant lymphoproliferative disease.
Meerbach A; Wutzler P; Häfer R; Zintl F; Gruhn B
J Med Virol; 2008 Mar; 80(3):441-54. PubMed ID: 18205222
[TBL] [Abstract][Full Text] [Related]
3. Fatal case of Epstein-Barr virus-induced lymphoproliferative disorder associated with a human immunodeficiency virus infection.
Beissner RS; Rappaport ES; Diaz JA
Arch Pathol Lab Med; 1987 Mar; 111(3):250-3. PubMed ID: 3030225
[TBL] [Abstract][Full Text] [Related]
4. [Clinical significance of Epstein-Barr virus load].
Dehée A
Ann Biol Clin (Paris); 2001 Oct; 59 Spec No():28-33. PubMed ID: 11675291
[No Abstract] [Full Text] [Related]
5. Associations among Epstein-Barr virus subtypes, human leukocyte antigen class I alleles, and the development of posttransplantation lymphoproliferative disorder in bone marrow transplant recipients.
Görzer I; Puchhammer-Stöckl E; van Esser JW; Niesters HG; Cornelissen JJ
Clin Infect Dis; 2007 Mar; 44(5):693-5. PubMed ID: 17278061
[TBL] [Abstract][Full Text] [Related]
6. Occurrence of post-transplant lymphoproliferative disorders among over thousand adult recipients: any role for hepatitis C infection?
Burra P; Buda A; Livi U; Rigotti P; Zanus G; Calabrese F; Caforio A; Menin C; Canova D; Farinati F; Luciana Aversa SM
Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1065-70. PubMed ID: 16957512
[TBL] [Abstract][Full Text] [Related]
7. First report of Epstein-Barr virus lymphoproliferative disease after cord blood transplantation.
Sirvent N; Reviron D; de Lamballerie X; Michel G
Bone Marrow Transplant; 2000 Jan; 25(1):120-1. PubMed ID: 10654028
[No Abstract] [Full Text] [Related]
8. Epstein-Barr virus-associated lymphoproliferative disorders.
Rezk SA; Weiss LM
Hum Pathol; 2007 Sep; 38(9):1293-304. PubMed ID: 17707260
[TBL] [Abstract][Full Text] [Related]
9. Cytomegalovirus and Epstein-Barr virus-associated post-transplant lymphoproliferative disorder after allogeneic hematopoietic stem cell transplantation.
Tsao SY; Chang KC; Chen YP; Yeh YM; Su WC; Chen TY
Ann Hematol; 2011 Jan; 90(1):113-4. PubMed ID: 20369358
[No Abstract] [Full Text] [Related]
10. B lymphocytes and Epstein-Barr virus: the lesson of post-transplant lymphoproliferative disorders.
Dolcetti R
Autoimmun Rev; 2007 Dec; 7(2):96-101. PubMed ID: 18035317
[TBL] [Abstract][Full Text] [Related]
11. Posttransplant lymphoproliferative disease, monoclonal, Epstein-Barr virus related.
Petrovic LM
Liver Transpl; 2001 May; 7(5):451-2. PubMed ID: 11349267
[No Abstract] [Full Text] [Related]
12. The impact of monitoring Epstein-Barr virus PCR in paediatric bone marrow transplant patients: can it successfully predict outcome and guide intervention?
Greenfield HM; Gharib MI; Turner AJ; Guiver M; Carr T; Will AM; Wynn RF
Pediatr Blood Cancer; 2006 Aug; 47(2):200-5. PubMed ID: 16206207
[TBL] [Abstract][Full Text] [Related]
13. Post-transplant lymphoproliferative disease and other Epstein-Barr virus diseases in allogeneic haematopoietic stem cell transplantation after introduction of monitoring of viral load by polymerase chain reaction.
Kinch A; Oberg G; Arvidson J; Falk KI; Linde A; Pauksens K
Scand J Infect Dis; 2007; 39(3):235-44. PubMed ID: 17366054
[TBL] [Abstract][Full Text] [Related]
14. Quantification of Epstein-Barr viral load and determination of a cut-off value to predict the risk of post-transplant lymphoproliferative disease in a renal transplant cohort.
Baiocchi OC; Colleoni GW; Caballero OL; Vettore AL; Andrade AL; Pestana JO
Haematologica; 2004 Mar; 89(3):366-8. PubMed ID: 15020282
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus polymerase chain reaction-negative stage IV post-transplant lymphoproliferative disorder in a heart transplant patient treated with rituximab.
Garceau P; Couture C; Cantin B; Bernier V; Sénéchal M
J Heart Lung Transplant; 2008 Aug; 27(8):928-31. PubMed ID: 18656811
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus-associated lymphoproliferative disorder presenting as apparently isolated gastrointestinal lesions in childhood.
Sebire NJ; Malone M; Risdon RA; Ramsay AD
Pediatr Dev Pathol; 2005; 8(1):88-91. PubMed ID: 15717118
[TBL] [Abstract][Full Text] [Related]
17. Fulminant Epstein-Barr virus (EBV)-associated T-cell lymphoproliferative disorder with hemophagocytosis following autologous peripheral blood stem cell transplantation for relapsed angioimmunoblastic T-cell lymphoma.
Awaya N; Adachi A; Mori T; Kamata H; Nakahara J; Yokoyama K; Yamada T; Kizaki M; Sakamoto M; Ikeda Y; Okamoto S
Leuk Res; 2006 Aug; 30(8):1059-62. PubMed ID: 16330097
[TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus-associated B cell lymphoproliferative disease after non-myeloablative allogeneic stem cell transplantation.
Milpied N; Coste-Burel M; Accard F; Moreau A; Moreau P; Garand R; Harousseau JL
Bone Marrow Transplant; 1999 Mar; 23(6):629-30. PubMed ID: 10217196
[TBL] [Abstract][Full Text] [Related]
19. Polyclonal Epstein-Barr virus-associated lymphoproliferative disorder following autografting for chronic myeloid leukemia.
Shepherd JD; Gascoyne RD; Barnett MJ; Coghlan JD; Phillips GL
Bone Marrow Transplant; 1995 Apr; 15(4):639-41. PubMed ID: 7655394
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus-associated central nervous system lymphoproliferative disease in a patient with acquired immunodeficiency syndrome responsive to highly active antiretroviral therapy.
Kuo DZ; Milstone AM; Omokaro SO; Friedman AD; Karanjawala ZE; Borowitz M; Joyner ML; Halsey NA; Sibinga EM
Clin Infect Dis; 2008 May; 46(9):1476-8. PubMed ID: 18419459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]